Literature DB >> 30237038

Emerging microRNAs in cancer diagnosis, progression, and immune surveillance.

Amani M Harrandah1, Rodrigo A Mora1, Edward K L Chan2.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that function in post-transcriptional regulation of gene expression. Dysregulation of miRNAs has been reported in different stages of cancer development and progression. This dysregulation results in different miRNA profiles between cancer and normal tissues. Many studies have shown a significant correlation between miRNA profile and cancer diagnosis and prognosis. Additionally, since a single miRNA regulates multiple mRNA targets, miRNAs dysregulation can affect several pathways involved in cancer development. Finally, due to their regulatory role in immune cell development, many recent studies have reported that certain miRNAs play key roles in cancer immunology. In this brief review, we discuss the role of miR-21 and miR-375 in the RAS pathway as well as their role in cancer diagnosis and progression, along with the role of other select miRNAs in cancer immune surveillance.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer immunity; Prognostic biomarker; RAS pathway; miR-21; miR-375; oncomiR

Mesh:

Substances:

Year:  2018        PMID: 30237038     DOI: 10.1016/j.canlet.2018.09.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  45 in total

1.  GNG12 Targeted by miR-876-5p Contributes to Glioma Progression Through the Activation of the PI3K/AKT Signaling Pathway.

Authors:  Ling Li; Qiuying Zhang; Leyong Yuan; Yanlong Yang; Xiaobo Wang; Fangfang Liu; Yang Liu; Mingshui Xie
Journal:  J Mol Neurosci       Date:  2022-01-27       Impact factor: 3.444

2.  Circ_0000140 restrains the proliferation, metastasis and glycolysis metabolism of oral squamous cell carcinoma through upregulating CDC73 via sponging miR-182-5p.

Authors:  Jia Guo; Yuanyuan Su; Meng Zhang
Journal:  Cancer Cell Int       Date:  2020-08-26       Impact factor: 5.722

3.  Circ_HIPK3 Knockdown Inhibits Cell Proliferation, Migration and Invasion of Cholangiocarcinoma Partly via Mediating the miR-148a-3p/ULK1 Pathway.

Authors:  Junning You; Xiaolin Wang
Journal:  Cancer Manag Res       Date:  2021-05-11       Impact factor: 3.989

4.  MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.

Authors:  Yunping Lu; Weifen Zheng; Xiao Rao; Yinggan Du; Jianbo Xue
Journal:  Biochem Genet       Date:  2022-02-04       Impact factor: 1.890

Review 5.  Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science.

Authors:  Yuening Xiang; Zimu Guo; Pengfei Zhu; Jia Chen; Yongye Huang
Journal:  Cancer Med       Date:  2019-04-03       Impact factor: 4.452

6.  Diagnostic and prognostic value of microRNA-193b in patients with glioma and its effect on tumor progression.

Authors:  Mingtao Zhu; Wei Zhao; Hui Zhao; Jing Zhang
Journal:  Oncol Lett       Date:  2019-09-06       Impact factor: 2.967

7.  Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.

Authors:  Ying Liu; Changchao Li; Huiqun Liu; Jing Wang
Journal:  Pharmacol Res Perspect       Date:  2021-08

8.  MicroRNA-455-5p Contributes to Cholangiocarcinoma Growth and Mediates Galangin's Anti-Tumor Effects.

Authors:  Xu Deng; Meiling Zuo; Zhifang Pei; Yuanlin Xie; Zhongbao Yang; Zhihui Zhang; Minna Jiang; Dabin Kuang
Journal:  J Cancer       Date:  2021-06-04       Impact factor: 4.207

9.  Long Non-Coding RNA GABPB1-AS1 Augments Malignancy of Glioma Cells by Sequestering MicroRNA-330 and Reinforcing the ZNF367/Cell Cycle Signaling Pathway.

Authors:  Xiulong Li; Hongfeng Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-10       Impact factor: 2.570

10.  A novel combination of serum microRNAs for the detection of early gastric cancer.

Authors:  Seiichiro Abe; Juntaro Matsuzaki; Kazuki Sudo; Ichiro Oda; Hitoshi Katai; Ken Kato; Satoko Takizawa; Hiromi Sakamoto; Fumitaka Takeshita; Shumpei Niida; Yutaka Saito; Takahiro Ochiya
Journal:  Gastric Cancer       Date:  2021-03-20       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.